Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Korosho to Promote Studies to Set Pediatric Doses
March 19, 2001
- Chuikyo Approves 3 New Advanced Medical Technologies
March 19, 2001
- Control Achieved in More than 65% of RA Patients in Long-term Outpatient Care: RDIC Seminar
March 19, 2001
- Notification Issued on ICH Stability Test Guidelines
March 19, 2001
- Significance of Genomic Base Sequence Other than Gene Code Should Be Studied: Prof. Shimizu
March 19, 2001
- REGULATORY NEWS IN BRIEF -1-
March 19, 2001
- PMSB to Issue Notification on Safety Management of Medical Radiation
March 19, 2001
- REGULATORY NEWS IN BRIEF -2-
March 19, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF
March 19, 2001
- Number of Elderly Outpatients Decreases Since January: Hodanren Survey
March 19, 2001
- WORLD NEWS IN BRIEF -1-
March 19, 2001
- Kyoritsu College of Pharmacy to Open Pharmacy
March 19, 2001
- WORLD NEWS IN BRIEF -2-
March 19, 2001
- Measures Taken to Prevent Medical Errors Reported: Safety Seminar
March 19, 2001
- Adsorption Type Hemocatharsis Device Designated as Orphan Device
March 19, 2001
- Over 90% of Nursing Staff Have Committed or Nearly Committed Errors
March 12, 2001
- Japan Tobacco to Make Pharma Business Profitable in FY2005
March 12, 2001
- BUSINESS NEWS IN BRIEF -2-
March 12, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
March 12, 2001
- Dainippon to Report Record-high Sales, Profits Again: President Miyatake
March 12, 2001
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…